Urocortin stimulates the ERK1/2 signaling pathway and the proliferation of HeLa cells via CRF receptor 1

FEBS Open Bio. 2023 May;13(5):818-832. doi: 10.1002/2211-5463.13602. Epub 2023 Apr 2.

Abstract

Corticotropin-releasing factor (CRF) stimulates adrenocorticotropic hormone (ACTH) secretion from the pituitary gland and is an essential regulator of the hypothalamic-pituitary-adrenocortical axis. Isoforms of CRF receptor are known to mediate the effects of urocortin stress ligands on the regulation of stress responses, anxiety, and feeding behavior; however, urocortin stress ligands also influence cell proliferation. In view of the tumor-promoting capacity of prolonged stress, here we investigated (a) the effect of urocortin on cell proliferative signaling via extracellular signal-regulated kinase 1/2, (b) the expression and cellular distribution of the specific CRF receptor isoforms, and (c) the intracellular localization of phosphorylated ERK1/2 in HeLa cells. Stimulation of cell proliferation was observed in the presence of 10 nm urocortin. Our data also suggest that MAP kinase MEK, the transcription factors E2F-1 and p53, and PKB/Akt are involved in this process. These findings may have therapeutic relevance for the targeted treatment of various malignancies.

Keywords: E2F-1; ERK1/2, MEK; HeLa; cell proliferation; urocortin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Corticotropin-Releasing Hormone / metabolism
  • Corticotropin-Releasing Hormone / pharmacology
  • HeLa Cells
  • Humans
  • Ligands
  • MAP Kinase Signaling System
  • Receptors, Corticotropin-Releasing Hormone* / metabolism
  • Urocortins* / metabolism
  • Urocortins* / pharmacology

Substances

  • Receptors, Corticotropin-Releasing Hormone
  • Urocortins
  • Ligands
  • Corticotropin-Releasing Hormone